Since the U.S. patent law switched to the first-inventor-to-file system in 2013, provisional applications have become more popular as the
Continue Reading Considerations for Protecting your Invention with Provisional Patent Applications
Dana-Farber Launches New Fund to Support Oncology Startups
2021 started off well for Dana-Farber Cancer Institute, with the launch of its new venture fund, Binney Street Capital,
Continue Reading Dana-Farber Launches New Fund to Support Oncology Startups
Practice Tips: Fair Use of a Trademark (Part II)
Sometimes it is necessary to use a third-party trademark to refer to the owner of a trademark or its goods
Continue Reading Practice Tips: Fair Use of a Trademark (Part II)
Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company
Continue Reading The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
Practice Tips: Fair Use of a Trademark (Part I)
One of the first things entrepreneurs will need to do when branding new companies is to seek and obtain trademark
Continue Reading Practice Tips: Fair Use of a Trademark (Part I)
Tips for Reviewing (or Drafting) Patent Claims
For emerging companies, a patent application should combine legal skill with technical and business knowledge to produce a document that
Continue Reading Tips for Reviewing (or Drafting) Patent Claims
Emerging Companies: Framework for Leveraging Your IP & Tech
Founders of technology-based companies often recognize very early on that their company’s IP and related technology comprise a significant or
Continue Reading Emerging Companies: Framework for Leveraging Your IP & Tech
Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?
As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the
Continue Reading Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?
Is it Time to Re-evaluate (or Create) Your Document Retention Policy?
In the fast-paced and dynamic environment of startup and emerging companies, standard operating procedures and compliance matters may often fall
Continue Reading Is it Time to Re-evaluate (or Create) Your Document Retention Policy?